Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | PSORS1C2 |
| Upstream (Parents) |
|---|
| (<<) ANTXR1 → PSORS1C2 |
| (<<) ARAF → PSORS1C2 |
| (<<) BMP8B → PSORS1C2 |
| (<<) CLCF1 → PSORS1C2 |
| (<<) KRT34 → PSORS1C2 |
| (<<) KRTAP1-3 → PSORS1C2 |
| (<<) MAPK1 → PSORS1C2 |
| (<<) MXRA8 → PSORS1C2 |
| (<<) MYL7 → PSORS1C2 |
| (<<) NFKBIB → PSORS1C2 |
| (<<) PLCD1 → PSORS1C2 |
| (<<) PRKAB1 → PSORS1C2 |
| (<<) SAA4 → PSORS1C2 |
| (<<) SMAD7 → PSORS1C2 |
| (<<) T → PSORS1C2 |
| (<<) UCA1 → PSORS1C2 |
| Downstream (Children) |
|---|
| PSORS1C2 → DISP2 (>>) |
| PSORS1C2 → EPHA4 (>>) |
| PSORS1C2 → EPHB6 (>>) |
| PSORS1C2 → FAM46B (>>) |
| PSORS1C2 → KLK8 (>>) |
| PSORS1C2 → LYNX1 (>>) |
| PSORS1C2 → MUC2 (>>) |
| PSORS1C2 → PCSK9 (>>) |
| PSORS1C2 → PLA2G3 (>>) |
| PSORS1C2 → SMOX (>>) |
| PSORS1C2 → SPINK5 (>>) |
| PSORS1C2 → TUBA4A (>>) |
| PSORS1C2 → TYRO3 (>>) |
